mohamed Essam El-Din ghoniem

Prof. Dr. mohamed Essam El-Din ghoniem

university of Ha'il, Saudi Arabia- Zagazig University, EGYPT
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2025 in Molecules
Verified
Journal Article
Open access
PDF file
Mohamed ElabbasyMohamed Elabbasy
Mohamed Elabbasy
RBRasha M. El Bayomi
Rasha M. El Bayomi
EAEsraa A. Abdelkarim
Esraa A. Abdelkarim
AHAbd El-Salam E. Hafez
Abd El-Salam E. Hafez
MOMohamed Othman
Mohamed Othman
MHMohamed A. Hussein
Mohamed A. Hussein
Multidrug-resistant (MDR) Escherichia coli is a major foodborne pathogen posing a critical threat to public health, particularly through the contamination of animal products. The increasing prevalence and virulence of MDR E. coli strains underscore the urgent need for alternative antimicrobial strategies. This study aimed to synthesize and characterize zinc oxide nanoparticles (ZnO-NPs) using Stevia rebaudiana as a sustainable capping and reducing agent, aligning with green chemistry principles. Of the 120 fish samples, 74.2% (89/120) were positive for E. coli contamination. Among the identified E. coli strains, 77.8% (119/153) were classified as MDR. Resistance profiling revealed 22 distinct patterns, and seven highly resistant and virulent strains were selected for further analyses. The eco-friendly auto-combustion synthesis of ZnO-NPs produced nanoparticles with semi-spherical to hexagonal shapes and an average size ranging from 12 to 25 nm. Scanning Electron Microscope–Energy Dispersive X-ray analysis (SEM-EDS) confirms that ZnO-NPs primarily consist of zinc (37.5%) and oxygen (19.9%), with carbon (42.6%) indicating the green synthesis process. ZnO-NPs demonstrated potent, dose-dependent antibacterial and antibiofilm activity against the selected MDR E. coli strains. Additionally, mechanistic studies revealed that ZnO-NPs disrupt bacterial cell membranes, alter cellular morphology, and interfere with DNA integrity. These findings highlight the potential of eco-friendly ZnO-NPs as a promising nanomaterial for enhancing food safety and addressing the growing challenge of MDR foodborne bacteria.

19 August 2021 in Medicina
Verified
Journal Article
Open access
PDF file
FAFahad Algahtani
Fahad Algahtani
Mohamed ElabbasyMohamed Elabbasy
Mohamed Elabbasy
MSMai A. Samak
Mai A. Samak
AAAdeniyi Adeboye
Adeniyi Adeboye
RYRafeek Yusuf
Rafeek Yusuf
MGmohamed Essam El-Din ghoniem
mohamed Essam El-Din ghoniem
Background and Objectives: Preventive, adjunctive and curative properties of lactoferrin have been evaluated since the first wave of severe acute respiratory syndrome coronavirus (SARS-CoV), a viral respiratory disease, emerged 18 years ago. Despite the discovery of new vaccine candidates, there is currently no widely approved treatment for SARS-CoV-2 (COVID-19). Strict adherence to infection prevention and control procedures, as well as vaccines, can, however, prevent the spread of SARS-CoV-2. This study aimed to evaluate the efficacy of lactoferrin treatment in improving clinical symptoms and laboratory indices among individuals with mild to moderate coronavirus disease-19 (COVID-19). Materials and Method: A randomized, prospective, interventional pilot study conducted between 8 July and 18 September 2020 used a hospital-based sample of 54 laboratory-confirmed participants with mild to moderate symptoms of COVID-19. Randomization into a control and two treatment groups ensured all groups received the approved Egyptian COVID-19 management protocol; only treatment group participants received lactoferrin at different doses for seven days. Clinical symptoms and laboratory indices were assessed on Days 0, 2 and 7 after starting treatments. Mean values with standard deviation and one-way analysis of variance with least significant difference of demographic and laboratory data between control and treatment groups were calculated. Results: Our study showed no statistically significant difference among studied groups regarding recovery of symptoms or laboratory improvement. Conclusions: Further research into therapeutic properties particularly related to dosage, duration and follow-up after treatment with lactoferrin in individuals with COVID-19 is required.

27 February 2025 in Nanomaterials
Verified
Journal Article
Open access
PDF file
Mohamed ElabbasyMohamed Elabbasy
Mohamed Elabbasy
RBRasha M. El Bayomi
Rasha M. El Bayomi
EAEsraa A. Abdelkarim
Esraa A. Abdelkarim
AHAbd El-Salam E. Hafez
Abd El-Salam E. Hafez
MOMohamed Othman
Mohamed Othman
MHMohamed A. Hussein
Mohamed A. Hussein
The rise of multidrug-resistant (MDR) bacteria in food products poses a significant threat to public health, necessitating innovative and sustainable antimicrobial solutions. This study investigates the green synthesis of zinc oxide nanoparticles (ZnO-NPs) using Stevia rebaudiana extracts to evaluate their antibacterial and antibiofilm activities against MDR Staphylococcus aureus strains isolated from sold fish samples. The obtained results show that the contamination with S. aureus reached 54.2% in the tested fish samples (n = 120), underscoring the urgent need for effective interventions. ZnO-NPs were successfully synthesized and characterized using UV-visible spectroscopy, FT-IR, XRD, and TEM, confirming their formation with an average size of 15.7 nm and reflecting their suitability for antimicrobial and biological applications. ZnO-NPs exhibited potent antibacterial activity, with a maximum inhibition zone of 24.4 ± 0.4 mm at 20 μg/disk, MIC values of 6.25–25 μg/mL, and MBC values of 12.5–50 μg/mL. Additionally, biofilm formation was inhibited by up to 92.1% at 250 μg/mL. Our mechanistic study confirmed that ZnO-NPs damage bacterial membranes and DNA, leading to the intracellular leakage of cell components that lead to bacterial cell lysis. The use of S. rebaudiana in ZnO-NP synthesis aligns with green chemistry principles, offering an eco-friendly alternative to conventional antibiotics and enhancing the bioactivity of ZnO-NPs, and may address the growing issue of antimicrobial resistance, thereby contributing to improved food safety and public health protection.

26 January 2024 in Archives of Biochemistry and Biophysics
Verified
Journal Article
Closed access
AAAsma Akhter
Asma Akhter
SASultan Alouffi
Sultan Alouffi
USUzma Shahab
Uzma Shahab
RARihab Akasha
Rihab Akasha
MFMohd Fazal-Ur-Rehman
Mohd Fazal-Ur-Rehman
Saheem AhmadSaheem Ahmad
Saheem Ahmad

18 March 2022 in Medicina
Verified
Journal Article
Open access
PDF file
FAFahad Algahtani
Fahad Algahtani
Mohamed ElabbasyMohamed Elabbasy
Mohamed Elabbasy
FAFares Alshammari
Fares Alshammari
AAAmira Atta
Amira Atta
AEAyman EL-Fateh
Ayman EL-Fateh
MGmohamed Essam El-Din ghoniem
mohamed Essam El-Din ghoniem
Background and Objectives: Within a year, COVID-19 has advanced from an outbreak to a pandemic, spreading rapidly and globally with devastating impact. The pathophysiological link between COVID-19 and acute kidney injury (AKI) is currently being debated among scientists. While some studies have concluded that the mechanisms of AKI in COVID-19 patients are complex and not fully understood, others have claimed that AKI is a rare complication of COVID-19-related disorders. Considering this information gap and its possible influence on COVID-19-associated AKI management, our study aimed to explore the prevalence of AKI and to identify possible risk factors associated with AKI development among COVID-19 hospitalized patients. Materials and Methods: A retrospective cohort study included 83 laboratory-confirmed COVID-19 patients hospitalized at the isolation department in a tertiary hospital in Zagazig City, Egypt between June and August 2020. Patients younger than 18 years of age, those diagnosed with end-stage kidney disease, or those on nephrotoxic medications were excluded. All study participants had a complete blood count, liver and renal function tests, hemostasis parameters examined, inflammatory markers, serum electrolytes, routine urinalysis, arterial blood gas, and non-enhanced chest and abdominal computer tomography (CT) scans. Results: Of the 83 patients, AKI developed in 24 (28.9%) of them, of which 70.8% were in stage 1, 8.3% in stage 2, and 20.8% in stage 3. Patients with AKI were older than patients without AKI, with hypertension and diabetes being the most common comorbidities. Risk factors for AKI include increased age, hypertension, diabetes mellitus, and a higher sequential organ failure assessment (SOFA) score. Conclusions: AKI occurs in a considerable percentage of patients with COVID-19, especially in elderly males, those with hypertension, diabetes, and a higher sequential organ failure assessment (SOFA) score. Hence, the presence of AKI should be taken into account as an important index within the risk spectrum of disease severity for COVID-19 patients.

31 January 2024 in Viruses
Verified
Journal Article
Open access
PDF file
KSKamal (short of Kamaleldin) Said
Kamal (short of Kamaleldin) Said
AAAhmed Alsolami
Ahmed Alsolami
KAKhalid F. Alshammari
Khalid F. Alshammari
SMSafia Moussa
Safia Moussa
FAFawaz Alshammeri
Fawaz Alshammeri
MGmohamed Essam El-Din ghoniem
mohamed Essam El-Din ghoniem
SARS-CoV-2 has caused the most devastating pandemic of all time in recent human history. However, there is a serious paucity of high-quality data on aggravating factors and mechanisms of co-infection. This study aimed to identify the trending patterns of bacterial co-infections and types and associated outcomes in three phases of the pandemic. Using quality hospital data, we have investigated the SARS-CoV-2 fatality rates, profiles, and types of bacterial co-infections before, during, and after COVID-19 vaccination. Out of 389 isolates used in different aspects, 298 were examined before and during the pandemic (n = 149 before, n = 149 during). In this group, death rates were 32% during compared to only 7.4% before the pandemic with significant association (p-value = 0.000000075). However, the death rate was 34% in co-infected (n = 170) compared to non-co-infected patients (n = 128), indicating a highly significant value (p-value = 0.00000000000088). However, analysis of patients without other serious respiratory problems (n = 28) indicated that among the remaining 270 patients, death occurred in 30% of co-infected patients (n = 150) and only 0.8% of non-co-infected (n = 120) with a high significant p-value = 0.00000000076. The trending patterns of co-infections before, during, and after vaccination showed a significant decline in Staphylococcus aureus with concomitant peaks in Gram negatives n = 149 before/n = 149 during, including Klebsiella pneumonian = 11/49 before/during, E. coli n = 10/24, A. baumannii n = 8/25, Ps. aeruginosa n = 5/16, and S. aureus 13/1. Nevertheless, in the post-vaccination phase (n = 91), gender-specific co-infections were examined for potential differences in susceptibility. Methicillin-resistant S. aureus dominated both genders followed by E. coli in males and females, with the latter gender showing higher rates of isolations in both species. Klebsiella pneumoniae declined to third place in male patients. The drastic decline in K. pneumoniae and Gram negatives post-vaccination strongly implied a potential co-protection in vaccines. Future analysis would gain more insights into molecular mimicry.